Otterfing, Germany

Nadja Harbeck


Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • München, DE (2007)
  • Otterfing, DE (2008)

Company Filing History:


Years Active: 2007-2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nadja Harbeck: Innovator in Diagnostic and Therapeutic Antibodies

Introduction

Nadja Harbeck is a prominent inventor based in Otterfing, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of diagnostic and therapeutic methods using antibodies. With a total of 2 patents, her work focuses on innovative solutions for detecting and treating diseases.

Latest Patents

Nadja's latest patents include a groundbreaking invention concerning the diagnostic and therapeutic use of antibodies against the urokinase receptor. This invention involves a method and a reagent kit for detecting cells in a biological sample using a double-fluorescence technique. The application of amino acid sequence-specific antibodies against the urokinase receptor demonstrates a high affinity for tumor cell-expressed receptors, showcasing her commitment to advancing medical diagnostics and therapies.

Career Highlights

Nadja Harbeck is associated with Wilex AG, a company known for its focus on innovative cancer therapies. Her role at Wilex AG has allowed her to collaborate with other experts in the field, further enhancing her contributions to biotechnology.

Collaborations

Some of her notable coworkers include Manfred Schmitt and Frank Noack. Their collaborative efforts have played a crucial role in the development of her patented technologies.

Conclusion

Nadja Harbeck's work in the field of diagnostic and therapeutic antibodies represents a significant advancement in medical science. Her innovative patents and collaborations highlight her dedication to improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…